News Headlines Article

Obamacare chief says UCSF research can help lower drug prices
San Francisco Chronicle

The Obama Administration’s top healthcare official said Thursday that personalized medicine research championed by UC San Francisco could help lower the cost of blockbuster drugs.

In a visit to the school’s Mission Bay campus, U.S. Health and Human Services Secretary Sylvia Burwell acknowledged the extraordinary cost of breakthrough therapies like Sovaldi, the hepatitis C drug made by Gilead Science in Foster City that costs $1,000 a pill.